Navigation Links
Muscular dystrophy diagnosis delayed almost 2.5 years in boys
Date:5/11/2009

Boys show signs of Duchenne Muscular Dystrophy (DMD) for 2 years before they obtain a diagnosis and disease-specific treatment, about the same length of delay children have endured for the past 20 years despite advances in genetic testing and treatment. A simple and inexpensive blood test for any boy with symptoms and signs of motor delays and abnormalities could speed up the process while pilot studies on newborn screening are conducted.

Recent University of Rochester Medical Center research published in the Journal of Pediatrics shows that boys who are eventually diagnosed with DMD show signs of the disease for more than a year before families bring it to the attention of a health care provider. It takes another year before these children are screened with a serum CK test a simple and inexpensive blood test for creatine kinase, an enzyme that leaks out of damaged muscle.

"The CK test is an easily available and cheap test," said Emma Ciafaloni, M.D., associate professor of Neurology at the University of Rochester Medical Center and author of the paper. "If they get the test and the diagnosis earlier, they can start treatment earlier and access the best care in the appropriate clinics and the best available services in their school. Early diagnosis will avoid unnecessary and costly tests and numerous unnecessary referrals to the wrong specialists. Parents and maternal relatives can also seek genetic counseling before they plan to have more children."

DMD, the most common muscular dystrophy in children is a particularly devastating form of the disease that affects 1 in 3,500 boys. It is an X-linked recessive genetic disease with onset of symptoms in boys between 2 and 6 years old. It progresses rapidly, rendering patients wheelchair bound by 10 or 11 years old. Most patients die in their mid-late 20s.

The Centers for Disease Control and Prevention-funded study analyzed medical records of 453 boys born since 1982 with
'/>"/>

Contact: Heather Hare
heather_hare@urmc.rochester.edu
585-273-2840
University of Rochester Medical Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. UVA reports surprising findings related to myotonic muscular dystrophy
2. Cold Spring Harbor Laboratory scientists devise potential approach to treat spinal muscular atrophy
3. Researchers discover molecular basis of a form of muscular dystrophy
4. Laminin builds the neuromuscular synapse
5. Study may explain exercise-induced fatigue in muscular dystrophies
6. Scientist clears hurdles for muscular dystrophy therapy
7. Potential therapy for congenital muscular dystrophy
8. Cell anchors required to prevent muscular dystrophy
9. While focusing on heart disease, researchers discover new tactic against fatal muscular dystrophy
10. March of Dimes awards $250,000 prize to scientists unraveling the causes of muscular dystrophy
11. 60 second test could help early diagnosis of common brain diseases

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...cillin-resistant Staphylococcus Aureus ) and othe...as low-temperature plasma prototype devices have b...ling bactericidal cocktails. , Two prototype dev...ection of healthy skin (e.g. hands and feet) in ho...a lethal threat; and another to shoot bacteria-kil...
(Date:11/25/2009)...r 11, firefighters, police officers and ambulance ...rld Trade Center complex. They battled to save peo...survivors, tackled fires and evacuated as many peo...timated 17,000 people. And making their jobs even ...ghtened workers and their relatives jammed mobile ...
(Date:11/25/2009)...ate University assistant professors recently recei...NSF) to continue research beneficial to understand...00. , Christopher Blackwood, assistant professor...rded grants to support two separate research proje...ter Decomposer Communities and Functions from the ...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Magic box for mission impossible 2Magic box for mission impossible 3Kent State University professors focus research on the environment with grants totaling $890,000 2Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 1Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 2Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 3Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 4Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 5Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 6Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 7Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 8Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 9Is it Exam Time for Students Already 3F 56191 1Is it Exam Time for Students Already 3F 56191 2Is it Exam Time for Students Already 3F 56191 3Is it Exam Time for Students Already 3F 56191 4Is it Exam Time for Students Already 3F 56191 5Adamas Pharmaceuticals to Present Data on Triple Combination Antiviral Drug Therapy for Drug Resistant Influenza at 2009 ICAAC Annual Meeting 13842 1Adamas Pharmaceuticals to Present Data on Triple Combination Antiviral Drug Therapy for Drug Resistant Influenza at 2009 ICAAC Annual Meeting 13842 2
... research shows that certain genes can influence a...es, cancer for example. New research at the Masoni...tes that genetic markers may also show a person,s ...rch study led by Brian Van Ness, Ph.D., has succes... with early clinical relapse of multiple myeloma, ...
...LE, Ariz. Oct. 21, 2008 TGen has spun off its th...medical information source for oncologists. , The...on a variety of data sources, including genetic-ba...-based Translational Genomics Research Institute. ...e oncologists with the knowledge they need to desi...
...zambiquein response to the urgent need to reduce t... Council for Science (ICSU) has launched a new, 10...o address the gaps in the knowledge and methods th...ence to averting disasters and reducing risk. The ...eral Assembly in Maputo, Mozambique. , Each year ...
Other Biology News:U of MN study shows link between gene variations and cancer survival 2TGen spin-off MedTrust Online enables cancer doctors to quickly obtain best-available information 2International Council for Science launches major research program on natural disasters 2
(Date:11/25/2009)...FirstCall/--ArdeaBiosciences,Inc.(Nasdaq: RDEA )an...chiefexecutiveofficer,willpresentatthePiperJaffray...tailsareasfollows:,PiperJaffray21stAnnualHealthCa...p.m.EasternTime,Location:TheNewYorkPalaceHotel,New...t/ireye/,target=,_blank,title=,http://www.corpora...
(Date:11/24/2009)...ewswire/--Twomoreprestigiousuniversitieshavejoined...dcareerssiteforlifescienceprofessionals. ,, Nor...bboard,joining28othermajorlifesciencetrainingInsti...m ,isonlyforpost-graduatesinthelifesciences.Whilet...et,BioCareerCenteristheonlyonethatserveslifescienc...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--deCODE,genetics,Inc.(Nasd...stday"motionsbytheU.S.BankruptcyCourtfortheDistric...iledavoluntarypetitionfor,reliefunderChapter11ofth.... , TheordersissuedbytheBankruptcyCourtallowt...hapter11proceedings.Inparticular,the,companyreceiv...
(Date:11/24/2009)...ecently approved the Promega PowerPlex 16 HS Syste...rating DNA records for the National DNA Index Syst...WEB) -- The FBI recently approved the Promega Pow...participating in, or generating DNA records for, t...y contains more than seven million profiles and ha...
Breaking Biology Technology:Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
...ta Green, a Project Which Will Leverage Rosetta Ge...ng IP Position to Develop a Wide ...s Recently Secured Up to $1.5M From Private Invest...renches as Certain Milestones are ...fied microRNAs Correlated With Algal Oil Content ...
...howed Patients Experienced Improvements in Quality...th Other Anti-TNFs or Methotrexate, SAN FRANCISCO... that patients receiving every four week subcutane...0 mg, an investigational therapy,experienced signi...elated,quality of life (HRQOL) and fatigue. The da...
... Oct. 27 /Xinhua-PRNewswire-FirstCall/ -- Tianyin,...cturer and supplier of,modernized traditional Chin... announced that the Company will present at the Ro... on Tuesday, November 11th, 2008. The,Conference w...ce Hotel in,New York City., The Company,s present...
Other Biology Technology:Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative 2Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative 3Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative 4Golimumab Phase 3 Data Show Significant Improvement In Physical Function In Patients with Rheumatoid Arthritis 2Golimumab Phase 3 Data Show Significant Improvement In Physical Function In Patients with Rheumatoid Arthritis 3Golimumab Phase 3 Data Show Significant Improvement In Physical Function In Patients with Rheumatoid Arthritis 4Golimumab Phase 3 Data Show Significant Improvement In Physical Function In Patients with Rheumatoid Arthritis 5Golimumab Phase 3 Data Show Significant Improvement In Physical Function In Patients with Rheumatoid Arthritis 6Golimumab Phase 3 Data Show Significant Improvement In Physical Function In Patients with Rheumatoid Arthritis 7Golimumab Phase 3 Data Show Significant Improvement In Physical Function In Patients with Rheumatoid Arthritis 8Golimumab Phase 3 Data Show Significant Improvement In Physical Function In Patients with Rheumatoid Arthritis 9Tianyin Pharmaceutical Co., Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York City on November 11, 2008 at 12:00 p.m. EST 2Tianyin Pharmaceutical Co., Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York City on November 11, 2008 at 12:00 p.m. EST 3
...GFX Purification Kit, 24 reactions. For the genera....Optimized reagents are packaged together for comp...ptimized protocols can be used for performing labe...leotides.Reliable purification using the CyScribe ...
Canine serum from Equitech-Bio
UV-NIR light source for USB2000, HR4000, HR2000+ from Ocean Optics
Mouse Anti-Human SIGIRR Monoclonal Antibody, Unconjugated, Clone 162201 from R&D Systems
Biology Products: